Rajthanee Hospital Public Company (RJH) Fair Value & Analysis
Healthcare · TH · Market cap 4.0B THB
Fair value as of: Jun 24, 2026
Analysis
Rajthanee Hospital Public Company (RJH) currently trades at 13.30 THB, while our model-based Fair Value estimate is 21.39 THB — implying the stock looks roughly 60.8% undervalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Rajthanee Hospital Public Company Limited, together with its subsidiaries, provides healthcare services in Thailand. The company operates medical centers, including trauma emergency and neurosurgery, non-trauma emergency, cardiology, minimally invasive surgery, surgery, orthopedic, wellness and occupational health, radiology, MRI, ophthalmology, hemodialysis, sleep lab, dental, physical therapy, and laboratory centers. It also operates pediatric and adolescent, pediatric for children of all ages and newborns, heart, pelvic floor rehabilitation, internal medicine, bone and joint, health and occupational examination, computerized tomography and diagnostic radiology, MRI, eye, tai chi, sleep health, dental, physical therapy, full-service laboratory, and comprehensive weight management center. In addition, provides internal medicine clinic specializing in hematology, ayurveda and integrated thai traditional medicine, specialized internal medicine for arthritis and rheumatism, dermatolog…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Rajthanee Hospital Public Company (RJH) undervalued?
What is the fair value of RJH?
What is the quality score of RJH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.